Peak Bio has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $100,000,000.00 in Post-IPO Equity.
According to filings with the U.S. Securities and Exchange Commission, Peak Bio is raising $100,000,000.00 in new funding. About Peak Bio: Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment…